Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
Cirillo A, Marinelli D, Romeo U, Messineo D, De Felice F, De Vincentiis M, Valentini V, Mezi S, Valentini F, Vivona L, Chiavassa A, Cerbelli B, Santini D, Bossi P, Polimeni A, Marchetti P, Botticelli A.
Cirillo A, et al. Among authors: vivona l.
BMC Cancer. 2024 Apr 8;24(1):430. doi: 10.1186/s12885-024-12155-3.
BMC Cancer. 2024.
PMID: 38589857
Free PMC article.